You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Johnson & Johnson is a multinational healthcare company that researches, develops, manufactures, and markets prescription medicines, medical devices, and (formerly) consumer health products. It operates primarily in the pharmaceuticals and medical‑technology sectors, with its Innovative Medicine segment focusing on oncology, immunology, neuroscience, cardiovascular and infectious‑disease therapies, while its MedTech segment provides surgical, orthopaedic, vision and interventional solutions. The firm is one of the world’s largest drug and biotechnology companies, widely recognized for a broad pipeline of patented medicines and a strong portfolio of medical‑device technologies, and it historically built a global brand through well‑known consumer items now housed in a separate company.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q4 FY26 | Jan 11, 2027 (est.) | — |
| Q3 FY26 | Oct 13, 2026 | $2.59 |
| Q2 FY26 | Jul 15, 2026 | $2.90 |
| Q1 FY26 | Apr 14, 2026 | $2.70 |
| Q4 FY25 | Jan 21, 2026 | $2.46 |
Stay ahead of JNJ earnings
Get reminders ahead of JNJ's next earnings report, so you always know when results are coming.